ABCL
ABCL
NASDAQ · Life Sciences Tools & Services

Abcellera Biologics Inc

Mid-Cap Stocks Healthcare Stocks
$12.82
+0.16 (+1.26%)
As of Sep 22, 2:15 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +249.5% upside
Low Target $32.90
Average Target $44.81
High Target $56.58
Current Price $12.82
Current
$12.82
Target
$44.81
$32.90 $44.81 avg $56.58
Scenario Analysis
Bear Case
$32.90
156.6%
Low target
Base Case
$44.81
+249.5%
Avg target
Bull Case
$56.58
+341.3%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$13.18
-2.7% from high
52-Week Low
$2.75
+367.0% from low
50-Day SMA
$3.99
+221.3% vs SMA
RSI (14)
58.5
Neutral
Target vs 52W High
$44.81
+240.0% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
 Strong Buy 36 81% $369.21 -43.9%
DHR
Danaher Corp
 Strong Buy 32 84% $158.11 -28.5%
IQV
Iqvia Holdings Inc
 Strong Buy 28 82% $82.96 -69.3%
A
Agilent Technologies Inc
 Strong Buy 30 77% $64.69 -61.3%
WAT
Waters Corp
 Buy 31 65% $189.60 -55.5%
ILMN
Illumina Inc
 Buy 28 57% $169.36 -31.6%
MTD
Mettler-Toledo International
 Hold 19 53% $170.43 -88.6%
WST
West Pharmaceutical Services
 Strong Buy 23 91% $136.24 -63.3%